3 recruiting, 3 unknown, 2 not yet recruiting, 1 active not recruiting. 5 Phase 1, 4 Phase 2, 2 Not applicable, 1 Phase 3.
Follow Low Dose Radiation Therapy: new trials by email Literature Review of Low Dose Radiation Therapy trials Research Report on Low Dose Radiation Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab Computed Tomography, Copper Cu 64-DOTA-pembrolizumab, Low Dose Radiation Therapy - Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain | Phase 1 | Recruiting | City of Hope Medical Center | 6 | 2026-09-01 | 2026-10-19 |
| Radiation to Treat Joint Damage Caused by Cancer Immunotherapy Low dose radiation therapy - Arthritis, Arthropathy | Phase 1 | Not yet recruiting | University of Chicago | 20 | 2026-08-26 | 2026-03-23 |
| Low-Dose Radiotherapy for Alzheimer's Disease Low Dose Radiation Therapy - Alzheimer Dementia, Dementia | Phase 1 / Phase 2 | Recruiting | Evan Thomas | 50 | 2026-07-15 | 2026-07-09 |
| Low Dose Radiotherapy for Osteoarthritis Low Dose Radiation Therapy - Osteoarthitis | Not applicable | Recruiting | Abramson Cancer Center at Penn Medicine | 113 | 2026-06-24 | 2026-09-21 |
| Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy Low Dose Radiation Therapy - Esophageal Adenocarcinoma, Radiotherapy | Phase 2 | Not yet recruiting | Fudan University | 32 | 2025-09-01 | 2025-09-10 |
| Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC Durvalumab, nanoparticle albumin bound paclitaxel, low dose radiation therapy - Stage III Non-small Cell Lung Cancer | Phase 1 | Unknown | Juan LI, MD | 9 | 2021-06-10 | 2021-12-15 |
| Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 Best Practice, Low Dose Radiation Therapy - Pneumonia, Severe Acute Respiratory Syndrome | Phase 3 | Unknown | Emory University | 14 | 2020-06-23 | 2023-08-14 |
| Low Dose Radiation Therapy for Covid-19 Pneumonia Low dose radiation therapy - COVID-19, Pneumonia | Not applicable | Unknown | All India Institute of Medical Sciences | 10 | 2020-06-13 | 2020-09-01 |
| Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 Low Dose Radiation Therapy - Pneumonia, Coronavirus Infection in 2019 (COVID-19) | Phase 1 / Phase 2 | Terminated | Emory University | 47 | 2020-04-24 | 2022-03-29 |
| Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma Low Dose Radiation Therapy - Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 51 | 2019-06-14 | 2026-06-03 |
COVID-19 (3) · Pneumonia (3) · Carcinoma, Non-Small-Cell Lung (2) · Severe Acute Respiratory Syndrome (2) · Adenocarcinoma Of Esophagus (1) · Alzheimer Disease (1) · Arthritis (1) · Brain Neoplasms (1) · Cytokine Release Syndrome (1) · Dementia (1) · Joint Diseases (1) · Lung Neoplasms (1) · Lymphoma, Mantle-Cell (1) · Osteoarthritis (1)
Emory University (2) · Abramson Cancer Center at Penn Medicine (1) · All India Institute of Medical Sciences (1) · City of Hope Medical Center (1) · Evan Thomas (1) · Fudan University (1) · Juan LI, MD (1) · M.D. Anderson Cancer Center (1) · University of Chicago (1)
United States (7) · China (1) · India (1)
Bouthaina S Dabaja (1) · Daya Nand Sharma, MD (1) · Evan Thomas, MD, PhD (1) · Mohammad K Khan, MD, PhD (1) · Mohammad Khan, MD, PhD (1) · Pankti Reid (1) · Sagus Sampath (1)
P30CA138292 (2), P30CA033572 (1)